| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031656309 |
| P356 | DOI | 10.1038/BMT.2011.213 |
| P698 | PubMed publication ID | 22056641 |
| P5875 | ResearchGate publication ID | 51773115 |
| P2093 | author name string | Y Wang | |
| H Chen | |||
| W Han | |||
| Y-H Chen | |||
| X-H Zhang | |||
| D-H Liu | |||
| L-P Xu | |||
| X-J Huang | |||
| F-R Wang | |||
| J-Z Wang | |||
| K-Y Liu | |||
| C-H Yan | |||
| P2860 | cites work | Pathophysiology and treatment of graft-versus-host disease | Q33769719 |
| Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation | Q34565838 | ||
| The search for optimal treatment in relapsed and refractory acute myeloid leukemia | Q34630777 | ||
| Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study | Q44552933 | ||
| Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. | Q45309204 | ||
| Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. | Q47362337 | ||
| Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect | Q47989352 | ||
| Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). | Q54023930 | ||
| Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation | Q66829606 | ||
| Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia | Q73687852 | ||
| Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience | Q74302216 | ||
| Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia | Q77769230 | ||
| Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions | Q79854792 | ||
| Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation | Q79879740 | ||
| Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies | Q80045677 | ||
| Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia | Q80514647 | ||
| Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia | Q81580798 | ||
| Regression modeling of competing risk using R: an in depth guide for clinicians | Q82452948 | ||
| Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect | Q83388964 | ||
| Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility | Q84742005 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| acute leukemia | Q976388 | ||
| risk factor | Q1475848 | ||
| P304 | page(s) | 1099-1104 | |
| P577 | publication date | 2011-11-07 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis | |
| P478 | volume | 47 |
| Q38124285 | Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation |
| Q97681405 | CTLA4Ig-primed donor lymphocyte infusions following haploidentical transplantation improve outcome with a distinct pattern of early immune reconstitution as compared to conventional donor lymphocyte infusions in advanced hematological malignancies |
| Q41031192 | Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation |
| Q90182584 | Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT |
| Q46779685 | Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation. |
| Q38842433 | Donor lymphocyte infusion after allogeneic stem cell transplantation |
| Q47994991 | Factors affecting the CD34+ cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor |
| Q28080452 | Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives |
| Q39805438 | Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. |
| Q90275244 | Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data |
| Q39670316 | Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update |
| Q51565423 | Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study. |
| Q38514490 | Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation. |
| Q42251937 | Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial. |
| Q33750829 | Irradiation of peripheral blood mononuclear cells with 7.5 Gy X-rays prior to donor lymphocyte infusion inhibits proliferation while preserving cytotoxicity, and improves the effectiveness of HSCT in patients with hematological malignancies |
| Q85268528 | Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center |
| Q38643400 | New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT. |
| Q39329093 | Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention |
| Q100737196 | Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis |
| Q35100974 | Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation |
| Q38863489 | Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT. |
| Q90305712 | Review of Haploidentical Hematopoietic Cell Transplantation |
| Q38660984 | Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation |
| Q49716061 | Strategies for improving the outcomes of allogeneic stem cell transplantation in patients with relapsed acute leukemia |
| Q87195951 | [Haploidentical hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia] |
| Q90389198 | [How I manage minimal residual disease positive patients with acute leukemia who underwent allogeneic stem cell transplantation] |
| Q88251347 | [Strategy to improve clinical outcome of unmanipulated haploidentical stem cell transplantation without in vitro T cell depletion] |
| Q88665506 | [The consensus of allogeneic hematopoietic transplantation for hematological diseases in China(2016)-- post- transplant leukemia relapse] |
Search more.